🌿 Environment 3d ago · Kristin Jensen

Roche KRAS drug succeeds in head-to-head lung cancer study

BioPharma Dive
BioPharma industry news
View Channel →
Roche KRAS drug succeeds in head-to-head lung cancer study
Source ↗ 👁 0 💬 0
The Phase 3 trial compared Roche’s divarasib with treatments sold by Amgen and Bristol Myers in patients with non-small cell lung cancer.

Comments (0)

Sign in to join the discussion

More Like This

'Very dangerous' super typhoon nears US Pacific islands
Earth News - Earth Science News, Earth Science, Climate Change · 14h ago
'This was something new': What people in Greenland told us about learning to live with wildfires
Earth News - Earth Science News, Earth Science, Climate Change · 20h ago
Trump victorious in legal battle to erase climate change and slavery signs from national parks
EHN · 1d ago
Australia welcomes draft UNESCO decision to keep Great Barrier Reef off danger list
EHN · 1d ago
Extreme heat is not an equal-opportunity killer
EHN · 1d ago
Trump pardons violators of the Clean Air Act
EHN · 1d ago